Oxford BioMedica plc Stock London S.E.
Equities
GB0006648157_GB
GB0006648157
Biotechnology & Medical Research
Sales 2023 * | 90.47M 113M | Sales 2024 * | 130M 162M | Capitalization | 229M 285M |
---|---|---|---|---|---|
Net income 2023 * | -89M -111M | Net income 2024 * | -38M -47.47M | EV / Sales 2023 * | 1.98 x |
Net cash position 2023 * | 49.23M 61.49M | Net cash position 2024 * | 15.5M 19.36M | EV / Sales 2024 * | 1.64 x |
P/E ratio 2023 * |
-2.51
x | P/E ratio 2024 * |
-5.94
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 80.81% |
Latest transcript on Oxford BioMedica plc
Managers | Title | Age | Since |
---|---|---|---|
Frank Mathias
CEO | Chief Executive Officer | 62 | 23-03-26 |
Stuart Paynter
DFI | Director of Finance/CFO | 52 | 17-08-28 |
Chairman | 68 | 20-06-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leone Patterson
BRD | Director/Board Member | 61 | 23-04-30 |
Chairman | 68 | 20-06-23 | |
Stuart Henderson
BRD | Director/Board Member | 66 | 16-05-31 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |